Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L S Marks

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Urology|February 14, 2007
Phase I/II examination of transurethral ethanol ablation of the prostate for the treatment of symptomatic benign prostatic hyperplasiaM K Plante, L S Marks, R Anderson, et al.
The Journal of Urology|September 1, 1996
Serum prostate specific antigen levels after transurethral resection of prostate: a longitudinal characterization in men with benign prostatic hyperplasiaL S Marks, F J Dorey, T Rhodes, et al.
Urology|May 19, 2001
Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgensL S Marks, D L Hess, F J Dorey, et al.
Analytical and Quantitative Cytology and Histology|January 9, 2001
Neural network prediction of prostate tissue composition based on magnetic resonance imaging analysis. A pilot studyI Simon, P B Snow, L S Marks, et al.
The Prostate|November 14, 2000
Seminal plasma contains "BPSA," a molecular form of prostate-specific antigen that is associated with benign prostatic hyperplasiaS D Mikolajczyk, L S Millar, K M Marker, et al.
Cancer Research|February 17, 2000
A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissueS D Mikolajczyk, L S Millar, T J Wang, et al.
Cancer Research|August 27, 1999
Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissueS D Mikolajczyk, L S Millar, K M Marker, et al.
The Journal of Urology|June 1, 1997
Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasiaL S Marks, A W Partin, G J Gormley, et al.
Urology|February 2, 2000
"BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasiaS D Mikolajczyk, L S Millar, T J Wang, et al.
The Journal of Urology|July 2, 1998
Influence of finasteride on free and total serum prostate specific antigen levels in men with benign prostatic hyperplasiaJ Pannek, L S Marks, J D Pearson, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Urology|February 14, 2007
Phase I/II examination of transurethral ethanol ablation of the prostate for the treatment of symptomatic benign prostatic hyperplasiaM K Plante, L S Marks, R Anderson, et al.
The Journal of Urology|September 1, 1996
Serum prostate specific antigen levels after transurethral resection of prostate: a longitudinal characterization in men with benign prostatic hyperplasiaL S Marks, F J Dorey, T Rhodes, et al.
Urology|May 19, 2001
Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgensL S Marks, D L Hess, F J Dorey, et al.
Analytical and Quantitative Cytology and Histology|January 9, 2001
Neural network prediction of prostate tissue composition based on magnetic resonance imaging analysis. A pilot studyI Simon, P B Snow, L S Marks, et al.
The Prostate|November 14, 2000
Seminal plasma contains "BPSA," a molecular form of prostate-specific antigen that is associated with benign prostatic hyperplasiaS D Mikolajczyk, L S Millar, K M Marker, et al.
Cancer Research|February 17, 2000
A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissueS D Mikolajczyk, L S Millar, T J Wang, et al.
Cancer Research|August 27, 1999
Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissueS D Mikolajczyk, L S Millar, K M Marker, et al.
The Journal of Urology|June 1, 1997
Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasiaL S Marks, A W Partin, G J Gormley, et al.
Urology|February 2, 2000
"BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasiaS D Mikolajczyk, L S Millar, T J Wang, et al.
The Journal of Urology|July 2, 1998
Influence of finasteride on free and total serum prostate specific antigen levels in men with benign prostatic hyperplasiaJ Pannek, L S Marks, J D Pearson, et al.
Pageof 6